EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiac glycosides inhibit early and late vaccinia virus protein expression

Jerzy Samolej, Ian J White, Blair L Strang, Jason Mercer

Journal of General Virology · 2024

DOI: 10.1099/jgv.0.001971 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Virology, 2024. Verfasst von Jerzy Samolej und 3 weiteren Autor:innen. Beteiligte Einrichtung: Insititute of Microbiology and Infection, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Cardiac Glycosides, Vaccinia, Poxviridae. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac glycosides (CGs) are natural steroid glycosides, which act as inhibitors of the cellular sodium-potassium ATPase pump. Although traditionally considered toxic to human cells, CGs are widely used as drugs for the treatment of cardiovascular-related medical conditions. More recently, CGs have been explored as potential anti-viral drugs and inhibit replication of a range of RNA and DNA viruses. Previously, a compound screen identified CGs that inhibited vaccinia virus (VACV) infection. However, no further investigation of the inhibitory potential of these compounds was performed, nor was there investigation of the stage(s) of the poxvirus lifecycle they impacted. Here, we investigated the anti-poxvirus activity of a broad panel of CGs. We found that all CGs tested were potent inhibitors of VACV replication. Our virological experiments showed that CGs did not impact virus infectivity, binding, or entry. Rather, experiments using recombinant viruses expressing reporter proteins controlled by VACV promoters and arabinoside release assays demonstrated that CGs inhibited early and late VACV protein expression at different concentrations. Lack of virus assembly in the presence of CGs was confirmed using electron microscopy. Thus, we expand our understanding of compounds with anti-poxvirus activity and highlight a yet unrecognized mechanism by which poxvirus replication can be inhibited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac GlycosidesVacciniaPoxviridaeHumansVaccinia virusVirus Replication

Stichwörter der Autor:innen

compounddruginfectionpoxvirusviral transcriptionvirion assembly

Substanzen

Cardiac Glycosides

Autor:innen und Institutionen

  • Insititute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
  • Laboratory for Molecular Cell Biology, University College London, London, UK.
  • Institute for Infection and Immunity, St George's, University of London, London, UK.

Förderung

  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Samolej, J., White, I. J., Strang, B. L., & Mercer, J. (2024). Cardiac glycosides inhibit early and late vaccinia virus protein expression. Journal of General Virology. https://doi.org/10.1099/jgv.0.001971

Vancouver

Samolej J, White IJ, Strang BL, Mercer J. Cardiac glycosides inhibit early and late vaccinia virus protein expression. Journal of General Virology. 2024. doi:10.1099/jgv.0.001971

BibTeX
@article{Samolej2024,
  author = {Samolej, Jerzy and White, Ian J and Strang, Blair L and Mercer, Jason},
  title = {Cardiac glycosides inhibit early and late vaccinia virus protein expression},
  journal = {Journal of General Virology},
  year = {2024},
  doi = {10.1099/jgv.0.001971}
}
Kostenlos starten →